908 Devices Inc

We maintain a bullish medium-term bias in this speculative stock amid a Stage 2 advance; however, near-term execution is deferred due to overextension and overbought conditions at recent highs. We await a pullback into the rising short-term EMAs for a more asymmetric entry zone. The long-term uptrend remains intact, supported by sequential higher highs and lows and rising major moving averages.

• ↑23% YoY revenue growth to $16.07M in Q2 2026 driven by VipIR demand
• ↑Raised full-year 2026 revenue guidance to $68–70M, implying 21%–25% growth
• ↓Adjusted EBITDA loss $1.9M and net loss $11.9M highlight ongoing profitability challenges